4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow Caspofungin: new trials by email Literature Review of Caspofungin trials Research Report on Caspofungin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) Caspofungin, Amphotericin B Deoxycholate - Candidiasis, Invasive | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 51 | 2014-01-15 | 2019-11-25 |
| Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) Caspofungin acetate, Placebo - Invasive Candidiasis | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 15 | 2010-12-01 | 2017-03-24 |
| Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems caspofungin acetate, voriconazole - Infection, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Terminated | OHSU Knight Cancer Institute | 13 | 2003-08-01 | 2025-04-27 |
| Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole L-743,872 - Candidiasis, Oral, HIV Infections | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 70 | 2005-06-24 |
Candidiasis, Invasive (2) · AIDS-Related Opportunistic Infections (1) · Candidiasis (1) · Candidiasis, Oral (1) · HIV Infections (1) · Infections (1) · Mycoses (1) · Pharyngeal Diseases (1)
Merck Sharp & Dohme LLC (3) · OHSU Knight Cancer Institute (1)
United States (2)